HUT77175A - Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények - Google Patents

Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények

Info

Publication number
HUT77175A
HUT77175A HU9700405A HU9700405A HUT77175A HU T77175 A HUT77175 A HU T77175A HU 9700405 A HU9700405 A HU 9700405A HU 9700405 A HU9700405 A HU 9700405A HU T77175 A HUT77175 A HU T77175A
Authority
HU
Hungary
Prior art keywords
epilectic
selegilin
treatment
conditions
production
Prior art date
Application number
HU9700405A
Other languages
English (en)
Other versions
HU223529B1 (hu
Inventor
Wolfgang Löscher
Original Assignee
Arzneimittelwerk Dresden Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh. filed Critical Arzneimittelwerk Dresden Gmbh.
Publication of HUT77175A publication Critical patent/HUT77175A/hu
Publication of HU223529B1 publication Critical patent/HU223529B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9700405A 1994-08-11 1995-07-27 Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására HU223529B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428444A DE4428444A1 (de) 1994-08-11 1994-08-11 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
PCT/DE1995/000981 WO1996004897A1 (de) 1994-08-11 1995-07-27 Verwendung von selegilin zur behandlung von epileptischen erkrankungen

Publications (2)

Publication Number Publication Date
HUT77175A true HUT77175A (hu) 1998-03-02
HU223529B1 HU223529B1 (hu) 2004-08-30

Family

ID=6525440

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700405A HU223529B1 (hu) 1994-08-11 1995-07-27 Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására

Country Status (23)

Country Link
US (1) US5952388A (hu)
EP (1) EP0774961B1 (hu)
JP (1) JP3922307B2 (hu)
CN (1) CN1081918C (hu)
AT (1) ATE239458T1 (hu)
AU (1) AU691316B2 (hu)
BR (1) BR9508531A (hu)
CA (1) CA2197176C (hu)
CZ (1) CZ285681B6 (hu)
DE (2) DE4428444A1 (hu)
DK (1) DK0774961T3 (hu)
EE (1) EE04176B1 (hu)
ES (1) ES2199252T3 (hu)
HU (1) HU223529B1 (hu)
MY (1) MY116362A (hu)
NO (1) NO314684B1 (hu)
PL (1) PL188040B1 (hu)
PT (1) PT774961E (hu)
RU (1) RU2155584C2 (hu)
SK (1) SK283205B6 (hu)
TR (1) TR199500984A2 (hu)
TW (1) TW448044B (hu)
WO (1) WO1996004897A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
EP1441708B1 (en) * 2001-11-05 2009-04-08 Krele Pharmaceuticals LLC Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
GB201715919D0 (en) * 2017-09-29 2017-11-15 Gw Res Ltd use of cannabinoids in the treatment of epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
AU1450592A (en) * 1991-04-04 1992-11-02 University Of Toronto Innovations Foundation, The Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5648087A (en) * 1993-03-09 1997-07-15 Sanofi Sante Nutrition Animale Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition

Also Published As

Publication number Publication date
ATE239458T1 (de) 2003-05-15
EE04176B1 (et) 2003-12-15
WO1996004897A1 (de) 1996-02-22
DK0774961T3 (da) 2003-09-01
CA2197176C (en) 2007-06-26
EE9700068A (et) 1997-10-15
AU691316B2 (en) 1998-05-14
MY116362A (en) 2004-01-31
DE4428444A1 (de) 1996-02-15
BR9508531A (pt) 1998-12-01
PT774961E (pt) 2003-09-30
NO970607D0 (no) 1997-02-10
US5952388A (en) 1999-09-14
CA2197176A1 (en) 1996-02-22
PL188040B1 (pl) 2004-11-30
HU223529B1 (hu) 2004-08-30
JPH10504029A (ja) 1998-04-14
CN1155241A (zh) 1997-07-23
TW448044B (en) 2001-08-01
ES2199252T3 (es) 2004-02-16
PL318292A1 (en) 1997-06-09
DE59510674D1 (de) 2003-06-12
MX9701031A (es) 1998-05-31
CZ40797A3 (en) 1997-07-16
AU2976095A (en) 1996-03-07
EP0774961A1 (de) 1997-05-28
CZ285681B6 (cs) 1999-10-13
JP3922307B2 (ja) 2007-05-30
NO970607L (no) 1997-02-10
SK283205B6 (sk) 2003-03-04
TR199500984A2 (tr) 1996-06-21
CN1081918C (zh) 2002-04-03
NO314684B1 (no) 2003-05-05
RU2155584C2 (ru) 2000-09-10
EP0774961B1 (de) 2003-05-07
SK19997A3 (en) 1997-08-06

Similar Documents

Publication Publication Date Title
GR3034162T3 (en) Liposome-encapsulated taxol, its preparation and its use
MY119403A (en) Novel compounds with analgesic effect.
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
ZA9432B (en) Use of anticonvulsants in the treatment of Parkinson's Disease and Parkinsonian Syndromes
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
GB9418912D0 (en) Pharmaceutically active compounds
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
MX9805141A (es) Uso de inhibidores del intercambiador celular na+/h+ (nhe) para la preparacion de un farmaco para estimular la respiracion.
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
HUT77175A (hu) Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények
HUT76801A (en) 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and medicaments containing them
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
IL110289A0 (en) Pharmaceutical compositions comprising 4'-iodo-4'- deoxydoxorubicin for treating amyloidosis
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
ZA9427B (en) Use of riluzole for promoting restoration following radiation
PL322847A1 (en) Condensed b-carbolins
UA42427A (uk) Спосіб корекції целюліту та/або локальних жирових відкладень
AU1195497A (en) Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: ASTA MEDICA AG, DE

DGB9 Succession in title of applicant

Owner name: VIATRIS GMBH CO. KG, DE

HFG4 Patent granted, date of granting

Effective date: 20040601

GB9A Succession in title

Owner name: MEDA PHARMA GMBH & CO. KG, DE

Free format text: FORMER OWNER(S): ARZNEIMITTELWERK DRESDEN GMBH., DE; ASTA MEDICA AG, DE; ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG, DE; VIATRIS GMBH CO. KG, DE; VIATRIS GMBH CO. KG, DE

MM4A Lapse of definitive patent protection due to non-payment of fees